Business Description
Genetic Signatures Ltd
ISIN : AU000000GSS4
Description
Genetic Signatures Ltd is engaged in the research and development into identifying and commercialisation of molecular diagnostics products to aid in the diagnosis of infectious diseases and the sale of associated products into the diagnostic and research marketplaces. Its segments are Reagents & consumables manufactures and sells 3base EasyScreen test kits for use in pathology laboratories to aid in the diagnosis of infectious diseases. Equipment sales and rental provides equipment to customers, either as an outright sale or under a lease arrangement, for use with the diagnostic test kits; and Service contracts provides service and maintenance for equipment used by customers It has three operating segments based on regions: Asia Pacific, EMEA, Americas.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 71.27 | |||||
Equity-to-Asset | 0.93 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | -0.02 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 0.85 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -23.9 | |||||
3-Year EBITDA Growth Rate | 6.7 | |||||
3-Year EPS without NRI Growth Rate | 18 | |||||
3-Year FCF Growth Rate | 34.7 | |||||
3-Year Book Growth Rate | -18.7 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 70.48 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 41.85 | |||||
9-Day RSI | 53.63 | |||||
14-Day RSI | 56.92 | |||||
3-1 Month Momentum % | -25.64 | |||||
6-1 Month Momentum % | -38.95 | |||||
12-1 Month Momentum % | -79.29 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 13.1 | |||||
Quick Ratio | 10.8 | |||||
Cash Ratio | 8.18 | |||||
Days Inventory | 306.1 | |||||
Days Sales Outstanding | 61.74 | |||||
Days Payable | 93.9 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -15.7 | |||||
Shareholder Yield % | 2.37 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 34.52 | |||||
Operating Margin % | -122.76 | |||||
Net Margin % | -96.91 | |||||
EBITDA Margin % | -108.49 | |||||
FCF Margin % | -61.01 | |||||
OCF Margin % | -53.76 | |||||
ROE % | -32.34 | |||||
ROA % | -29.56 | |||||
ROIC % | -105.73 | |||||
3-Year ROIIC % | 22.16 | |||||
ROC (Joel Greenblatt) % | -113.73 | |||||
ROCE % | -40.77 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 1.28 | |||||
PB Ratio | 0.51 | |||||
Price-to-Tangible-Book | 0.51 | |||||
EV-to-EBIT | 0.11 | |||||
EV-to-EBITDA | 0.13 | |||||
EV-to-Revenue | -0.14 | |||||
EV-to-Forward-Revenue | 5.72 | |||||
EV-to-FCF | 0.23 | |||||
Price-to-GF-Value | 0.24 | |||||
Price-to-Median-PS-Value | 0.11 | |||||
| Price-to-Net-Current-Asset-Value | 0.58 | |||||
| Price-to-Net-Cash | 0.9 | |||||
Earnings Yield (Greenblatt) % | 909.09 | |||||
FCF Yield % | -44.62 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Genetic Signatures Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 14.453 | ||
| EPS (TTM) (A$) | -0.062 | ||
| Beta | 0.0664 | ||
| 3-Year Sharpe Ratio | -0.58 | ||
| 3-Year Sortino Ratio | -0.81 | ||
| Volatility % | 89.11 | ||
| 14-Day RSI | 56.92 | ||
| 14-Day ATR (A$) | 0.005539 | ||
| 20-Day SMA (A$) | 0.0738 | ||
| 12-1 Month Momentum % | -79.29 | ||
| 52-Week Range (A$) | 0.051 - 0.43 | ||
| Shares Outstanding (Mil) | 227.14 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Genetic Signatures Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Genetic Signatures Ltd Stock Events
| Event | Date | Price (A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Genetic Signatures Ltd Frequently Asked Questions
What is Genetic Signatures Ltd(ASX:GSS)'s stock price today?
The current price of ASX:GSS is A$0.08. The 52 week high of ASX:GSS is A$0.43 and 52 week low is A$0.05.
When is next earnings date of Genetic Signatures Ltd(ASX:GSS)?
The next earnings date of Genetic Signatures Ltd(ASX:GSS) is .
Does Genetic Signatures Ltd(ASX:GSS) pay dividends? If so, how much?
Genetic Signatures Ltd(ASX:GSS) does not pay dividend.
Articles on Genetic Signatures Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers